Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fabric Genomics Inc. is active in the Biotechnology & Pharmaceuticals technology area with its patent portfolio. The data indicates there is 1 pending office action currently in progress. This single action represents the total active engagement between the company and the patent office regarding its pending intellectual property claims. This suggests a focused strategy on a particular genomic or biotechnological advancement.
The examination of this portfolio is highly centralized, involving 1 distinct examiner and 1 distinct art unit. This concentration suggests that the company technology is being evaluated by a single specialized division. The presence of only one art unit implies that the technical scope of the current filings is narrow and does not cross into other regulatory domains, which can streamline the prosecution process.
SMITH, EMILIE ALINE is the busiest examiner for the portfolio, currently managing 1 pending office action. As the busiest examiner pending count is 1, this examiner handles all active matters for the company. The prosecution outcome for the company biotechnology innovations is therefore tied to the specific determinations made by this single examiner, providing a clear and singular point of contact for legal strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SMITH, EMILIE ALINE | 1 | 49.4% | +35.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17684853 | METHODS OF ANALYZING GENETIC VARIANTS BASED ON GENETIC MATERIAL | SMITH, EMILIE ALINE | 12d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17684853 | METHODS OF ANALYZING GENETIC VARIANTS BASED ON GENETIC MATERIAL | SMITH, EMILIE ALINE | 12d |
| Art Unit | Apps |
|---|---|
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17684853 | METHODS OF ANALYZING GENETIC VARIANTS BASED ON GENETIC MATERIAL | SMITH, EMILIE ALINE | 1686 | §101§112 | Final Rejection | 12d | Pending | Mar 02, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial